首页
外语
计算机
考研
公务员
职业资格
财经
工程
司法
医学
专升本
自考
实用职业技能
登录
考研
Read the following text and match each of the numbered items in the left column to its corresponding information in the right co
Read the following text and match each of the numbered items in the left column to its corresponding information in the right co
admin
2022-12-09
121
问题
Read the following text and match each of the numbered items in the left column to its corresponding information in the right column. There are two extra choices in the right column. Mark your answers on the ANSWER SHEET.
In a state-of-the-art clean room, a scientist clad in a full-body containment suit, a hair net and blue gloves is preparing some printing cartridges—filled not with ink but a viscous milky liquid. Next to her sits a computer connected to a machine that resembles a large ice-cream dispenser, except that each of its two nozzles is made of a syringe with a long needle. Once the scientist clicks on the "run program" button, the needles squeeze not a vanilla or chocolate flavoured treat, but a paste of living cells.
Forty minutes later, the task is finished. Depending on the choice of bioink and printing pattern, the result could have been any number of three-dimensional biological structures. In this case, it is a strand of living lung tissue about 4cm in length and containing about 50m cells.
Since its start in 2007, researchers at San Diego-based Organovo have experimented with printing a wide variety of tissues, including bits of lung, kidney and heart muscle. Now the world’s first publicly traded 3D bioprinting company is gearing up for production. In January samples of its first product—slivers of human liver tissue—were delivered to an outside laboratory for testing. These are printed in sets of 24 and take about 30 minutes to produce, says Keith Murphy, the firm’s chief executive. Later this year Organovo aims to begin commercial sales.
Each set consists of a plate with 24 wells containing a piece of liver tissue 3mm square and 0.5mm deep. Although prices have not been fixed, a set of tissues like this can sell for $2,000 or more for laboratory use. It might seem expensive, but it could save pharmaceutical companies a lot of money. This is because Organovo’s research indicates that the slivers of liver respond to drugs in many ways like a fully grown human liver would. If this is confirmed by outside testing, researchers could use the printed tissues to test the toxicity of new drugs before deciding whether to embark on expensive clinical trials with patients.
The invention of 3D printing in the 1980s provided a technology now used to manufacture everything from aircraft parts to prosthetic limbs. But the promise of 3D bioprinting is even larger: to create human tissues—layer by layer—for research, drug development and testing, and ultimately as replacement organs, such as a kidney or pancreas, for patients desperately in need of a transplant. Bioprinted organs could be made from patients’ own cells and thus would not be rejected by their immune systems. They could also be manufactured on demand.
At present only a handful of companies are trying to commercialize the production of bioprinted tissues. But Thomas Boland, an early pioneer in the field, says that plenty of others are interested and estimates that about 80 teams at research institutions around the world are now trying to print small pieces of tissues as varied as skin, cartilage, blood vessels, liver, lung and heart. "It’s a wonderful technology to build three-dimensional biological structures," says Gabor Forgacs, who co-founded Organovo in 2007 and was the company’s scientific mastermind.
[A] would be made on the need of the market.
[B] said that bioprinting was a wonderful technology.
[C] could be made from the cells of patients’ relatives.
[D] claimed that it took a short time to print the tissues.
[E] showed that the printed tissues were similar to real tissues.
[F] reckoned that bioprinting appealed to a majority of companies.
[G] conducted a large number of experimental studies of bioprinting.
Organovo’s research
选项
答案
E
解析
根据Organovo’s research定位至第四段。第四句This is because Organovo’s research indicates that the slivers of liver respond to drugs in many ways like a fully grown human liver would (这是因为,Organovo的研究表明,打印出的肝组织切片在许多方面对药物的反应与发育完全的人类肝脏一致)。与该句表述意义相近的是选项E,表明打印出来的人体组织与真正的人体组织相似,这与原文“打印出的肝组织切片在许多方面对药物的反应与发育完全的人类肝脏一致”基本吻合。故本题答案为E。
转载请注明原文地址:https://kaotiyun.com/show/lQMD777K
0
考研英语二
相关试题推荐
Scientistssentpatternsofelectricitycoursingacrosspeople’sbrains,coaxingtheirbrainstoseelettersthatweren’tthere.
Writeanessaybasedonthechartbelow.Inyourwriting,youshould1)interpretthechart,and2)giveyourcomments.Youshou
SelectiveNewYorkCitypublichighschoolsaresupposedtomakeiteasyforfamiliestoseetheirdetailedadmissioncriteria,
WhatComesNextAftertheDeathofFreeMarket?WhentheCovid-19pandemicstruck,worldmarketscametoastandstill.Gover
WhatComesNextAftertheDeathofFreeMarket?WhentheCovid-19pandemicstruck,worldmarketscametoastandstill.Gover
"Universalhistory,thehistoryofwhatmanhasaccomplishedinthisworld,isatbottomtheHistoryoftheGreatMenwhohavew
"Universalhistory,thehistoryofwhatmanhasaccomplishedinthisworld,isatbottomtheHistoryoftheGreatMenwhohavew
Thinnerisn’talwaysbetter.Anumberofstudieshave【C1】________thatnormal-weightpeopleareinfactathigherriskofsomedi
SupposeyouareamemberoftheStudents’Unionandyouruniversitywillholdanexperiencesharingmeetingaboutthepostgradua
Peoplehavebeenholdingheateddiscussionsrecentlyaboutwomen’sexperienceintheworkplace.LastmonthSherylSandberg,chie
随机试题
手太阴肺经的起止穴分别是手厥阴心包经起止穴分别是
A、可以降低混悬液中微粒的沉降速度B、可以增加难溶药物在水中的溶解度C、可以提高溶胶的稳定性D、可以加速乳剂的乳析E、可以阻碍混悬液中微粒发生碰撞聚集反絮凝剂
只要一国的国际收支平衡表是平衡的,该国的国际收支就是平衡的。()
楔形偶尔也可能出现在顶部或底部而作为反转形态。( )
下列社会保险险种中,企业职工个人不缴费的是()。
关于幼儿无意想象的特点,下列说法正确的是()。
“既见森林又见树木”指的是()。
关中地区位于陕西中部,土地肥沃、物产丰富,古称“陆海”,具有优越的自然条件和良好的生态环境,是我国历史上最早的“天府之国”。早在旧石器时代,关中地区就已经有人类繁衍生息。西周时期,这里曾经是全国的政治、经济中心,其后经过秦人的开发,这里就变得更加富庶。历史
设3阶矩阵A的各行元素之和都为2,又α1=(1,2,2)T和α2=(0,2,1)T分别是(A-E)X=0的(A+E)X=0的解.(1)求A的特征值与特征向量.(2)求矩阵A.
建立一个供应商、零件数据库。其中“供应商”表S(Sno,Sname,Zip,City)分别表示:供应商代码、供应商名、供应商邮编、供应商所在城市,其函数依赖为:Sno→(Sname,Zip,City),Zip→City。“零件”表P(Pno,Pname,
最新回复
(
0
)